A randomised phase III study of single fraction radiotherapy compared to multifraction radiotherapy in patients with metastatic spinal cord compression

Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression. This randomised clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.

Primary Sponsor

University College London (UCL)

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

694

Trial Chairperson

Dr Tanya Holt

Trial Contact

Kacy.Baumann@health.qld.gov.au

Related Post

31 March, 2026

TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes

LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to